XCT0135908

Contact us
TargetMol
Product Code: TAR-T35159
Supplier: TargetMol
CodeSizePrice
TAR-T35159-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35159-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35159-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1
❮❯

Documents

Further Information

Bioactivity:
XCT0135908 is a selectivity agonist of RXR -Nurr1 over a broad range of other RXR dimerization partners but with a rather low potency.
CAS:
300837-31-4
Formula:
C21H19N3O2
Molecular Weight:
345.402
Purity:
0.98
SMILES:
Cc1nc(nc(Nc2ccc(cc2)C(O)=O)c1CC=C)-c1ccccc1

References

Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury By Gurney, Mark E.; Atkins, Collen M.; Adaikkalasamy, David J.; Dietrich, W. Dalton From U.S. Pat. Appl. Publ. (2014), US 20140121221 A1 20140501. | Language: English, Database: CAPLUS Treatment of neurodegenerative diseases using retinoid X receptor (RXR)?-?selective agonists By Burstein, Ethan S.; Olsson, Roger; McFarland, Krista From Eur. Pat. Appl. (2013), EP 2556827 A1 20130213. | Language: English, Database: CAPLUS Preparation of 4-?amino substituted condensed pyrimidine compounds as selective PDE4 inhibitors useful in treatment of diseases By Konetzki, Ingo; Jakob, Florian; Craan, Tobias; Hesslinger, Christian From PCT Int. Appl. (2014), WO 2014117947 A1 20140807. | Language: English, Database: CAPLUS Treatment of neurodegenerative diseases using retinoid X receptor (RXR)?-?selective agonists By Burstein, Ethan S.; Olsson, Roger; McFarland, Krista From PCT Int. Appl. (2013), WO 2013020966 A1 20130214. | Language: English, Database: CAPLUS